TP53 and lung carcinoma: Furthermore, we analyzed p53 mutational status in the series of lung cancer patients used for tissue miRNA profiling and we found p53 mutations in 9 out of 20 patients, but the p53 status did not correlate (P=0.37) with mir-660 expression levels.